China biotech deals hit record as innovative drugs draw interest of multinationals
Story summaryDeals reach US$60 billion in first quarter after analysts say Chinese biotech firms have shown substantial technological advancements
Read at South China Morning PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.